Interferon augments PML and PML/RARα expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line

Blood

Volumn 88, Issue 10, 1996, Pages 3926-3936

  Nason Burchenal, Kathryn ^b   Gandini, Domenica ^b   Botto, Marina ^b   Allopenna, Janet ^b   Seale, James R C ^b   Cross, Nicholas C P ^b   Goldman, John M ^b   Dmitrovsky, Ethan ^b   Pandolfi, Pier Paolo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERFERON; RECOMBINANT ALPHA INTERFERON A; RECOMBINANT GAMMA INTERFERON; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL VIABILITY; CHROMOSOME TRANSLOCATION 15; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TRANSCRIPTION REGULATION;

EID: 0029803774     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3926.bloodjournal88103926     Document Type: Article

References (54)

1. Bennett JM, Catovsky D, Daniel D, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposal for the classification of the acute leukaemias. Br J Haematol 33:451, 1976
2. Groopman J, Ellman L: Acute promyelocytic leukemia. Am J Hematol 7:395, 1979
3. Stone RM, Mayer RJ: The unique aspects of acute promyelocytic leukaemia. J Clin Oncol 8:1913, 1990
4. Huang M, Yu-Chen Y, Shu-Rong C, Chai J, Lin Z, Long J, Wang Z: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
5. Degos L, Chomienne C, Daniel MT, Berger R, Dombret H, Fenaux P, Castaigne S: Treatment of first relapse in acute promyelocytic leukemia with all-trans retinoic acid. Lancet 336:1440, 1990
6. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MSS, Dmitrovsky E: Differentiation therapy for acute promyelocytic leukemia with tretinoin (all-trans retinoic acid), N Engl J Med 324:1385, 1991
7. Fenaux P, Castaigne S, Dombret H, Archimbald E, Duarte M, Morel P, Tilly TH, Guerci A, Maloisel F, Bordessoule D, Sadoun A, Tiberghien P, Fegueux N, Daniel MT, Chomienne C, Degos L: All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 80:2176, 1992
8. Castaigne S, Chomienne C, Daniel MT, Berger R, Fenaux P, Degos L: All-trans retinoic acid as a differentiating therapy for acute promyelocytic leukemia I. Clinical results. Blood 76:1704, 1990
9. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L: All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship. Blood 76:1710, 1990
10. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A: The t(15; 17)translocation of acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 347:558, 1990
11. Borrow J, Goddard AD, Sheer D, Solomon E: Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249:1577, 1990
12. Alcalay M, Zangrilli D, Pandolfi PP, Longo L, Mencarelli A, Giacomucci A, Rocchi M, Biondi A, Rambaldi A, Lo Coco F, Diverio D, Donti E, Grignani F, Pelicci PG: Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor a locus. Proc Natl Acad Sci USA 88:1977, 1991
13. Longo L, Pandolfi PP, Biondi A,Rambaldi A, Mencarelli A, Lo Coco F, Diverio D, Alcalay M, Donti E, Grignani F, Pelicci PG: Rearrangements and aberrant expression of the retinoic acid receptor a gene in acute promyelocytic leukemia. J Exp Med 172:1571, 1990
14. Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285, 1991
15. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM: Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663, 1991
16. de Thé H, Lavau C, Marehio A, Chomienne C, Degos L, Dejean A: The PML/RARα fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
17. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A,Grignani F, Rochette-Egly C, Gaube MP, Chambon P, Pelicci PG: Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukemia. EMBO J 11:1397, 1992
18. Alcalay M, Zangrilli D, Fagioli M, Pandolfi PP, Mencarelli A, Lo Coco F, Biondi A, Grignani F, Pelicci PG: Expression pattern of the RARα-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89:4840, 1992
19. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Acute promyelocytic leukemia: From genetics to treatment. Blood 83:10, 1994
20. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P: PML/RAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR. EMBO J 12:3171, 1993
21. Grignani FR, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
22. Chambon P, Zelent A, Petkovich M, Mendelsohn C, Leroy P, Krust A,Kastner P, Brand N: The family of retinoic acid nuclear receptors, in JH Saurat (ed): Retinoids: 10 Years On.... Basel, Switzerland, Karger, 1991, p 10
23. Zelent A: Translocation of the RARα locus to the PML or PLZF gene in acute promyelocytic leukemia. Br J Haematol 86:451, 1994
24. Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS: PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14:6858, 1994
25. Liu JH, Mu ZM, Chang KS: PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J Exp Med 181:1965, 1995
26. Chang KS, Fan YH, Andreeff M, Liu J, Mu ZM: The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85:3646, 1995
27. Borden KLB, Boddy MN, Lally J. OÕReilly J, Martin S, Howe K, Solomon E, Freemont PS: The solution structure of the RING finger domain from the acute promyelocytic leukemia protooncoprotein PML. EMBO J 14:1532, 1995
28. Koken MHM, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J,Juhlin L, Degos L, Calvo F, de Thé H: The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10:1315, 1995
29. Everett RD, Maul GG: HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 13:5062, 1994
30. Maul GG, Everett RD: The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is re-arranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol 75:1223, 1994
31. Lavau C, Marchio A, Fagioli M, Jansen J, Falini B, Lebon P, Grosveld F, Pandolfi PP, Pelicci PG, Dejan A: The PML gene is a primary target for Interferon. Oncogene 11:871, 1995
32. Cassatella MA, Capelli R, Della Bianca V, Grzeskowiak M, Dusi S, Berton G: Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis. Immunology 63:499, 1988
33. Cassatella MA, Della Bianca V, Berton G, Rossi F: Activation by gamma Interferon of human macrophage capability to produce toxic oxygen molecules is accompanied by decreased km of the superoxide-generating NADPH oxidase. Biochem Biophys Res Commun 132:908, 1985
34. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
35. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983
36. Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A, Acampora D, Grignani F, Pelicci PG: Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7:1083, 1992
37. Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ, Kirschner MW: Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and γ-actin genes using specific cloned c-DNA probes. Cell 20:95, 1980
38. Flenghi L, Fagioli M Tomassoni L, Pileri S, Gambacorta M, Pacini R, Grignani F, Casini T, Ferrucci PF, Martelli MF, Pelicci PG, Falini B: Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: Immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85:1871, 1995
39. Seale JRC, Varma S, Swirsky DM, Pandolfi PP, Goldman JM, Cross NCP: Quantification of PML-RARα: transcripts in acute promyelocytic leukemia: Explanation for the lack of sensitivity of RT- PCR for the detection of minimal residual disease and induction of the leukemia specific mRNA by alpha interferon. Br J Haematol (in press)
40. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15; 17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
41. Ahn MJ, Nason-Burchenal K, Moasser M, Dmitrovsky E: Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RARα or PML. Oncogene 10:2307, 1995
42. Denizot F, Lang R: Rapid colorimetric assay for cell growth and survival. J Immunol Methods 89:271, 1986
43. Daniel MT, Koken M, Romagne O, Barbery S,Bazarbachi A, Stadler M, Guillemin MC, Degos L, Chomienne C, de Thé H: PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82:1858, 1993
44. Bollag W, Peck R: Modulation of growth and differentiation by combined retinoids and cytokines in cancer, in Hong WK, Lotan R (eds): Retinoids in Oncology. New york, NY, Marcel Dekker, 1993, p 89
45. Hemmi H, Breitman TR: Combination of recombinant human interferons and retinoic acid synergistically induce differentiation of the human promyelocytic leukemia cell line HL-60. Blood 69:501, 1987
46. Trinchieri G, Rosen M, Perussia B: Retinoic acid cooperates with tumor necrosis factor and immune interferon in inducing differentiation and growth inhibition of the human promyelocytic leukemic cell line HL-60. Blood 69:1218, 1987
47. Kohlhepp EA, Condon ME, Hamburger AW: Recombinant human interferon a enhancement of retinoic-acid-induced differentiation of HL-60 cells. Exp Hematol 15:414, 1987
48. Ho CK: Synergistic anticellular effect of a combination of β-interferon and retinoic acid against U937 cells. Cancer Res 45:5348, 1985
49. Chelbi-Alix MK, Pelicano L, Quignon F, Kiken MHM, Venturini L, Stadler M, Pavlovic J, Degos L, de Thé H: Induction of the PML protein by interferons in normal and APL cells. Leukemia 9:2027, 1995
50. Stadler M, Chelbi-Alix MK, Koken MHM, Venturini L, Lee C, Sab A, Quignon F, Pelicano L, Guillemin M-C, Schindler C, de Thé H: Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11:2565,1996
51. Koller E, Krieger O, Kasparu H, Lutz D: Restoration of all-trans retinoic acid sensitivity by interferon in acute promyelocytic leukemia. Lancet 338:1154, 1991
52. Warrell RP Jr: Retinoid resistance. Lancet 341:126, 1993 (letter)
53. Dermime S, Grignani FR, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG, Gambacorti-Passerini C: Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB306 is associated with altered expression of the PML/RARα protein. Blood 82:1573, 1993
54. Licht JD, Chomienne C, Goy A, Chen A, Scott A, Head DR, Michaux JL, Wu Y, DeBlasio A, Miller WH, Zelenetz AD, Willman CL, Chen Z, Chen SJ, Zelent A, Macintyre E, Veil A, Cortes J, Kantarjia H, Waxman S: Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11; 17). Blood 85:1083, 1995